Vice President Biden and Dr. Jill Biden will host a Cancer Moonshot Summit in Washington, D.C. at the White House. Cheryl Willman, MD, Director and CEO of The University of New Mexico Comprehensive Cancer Center, will attend. At the same time, the UNM Comprehensive Cancer Center will host a local Cancer Moonshot Summit.
A study by UNC Lineberger Comprehensive Cancer Center researchers has revealed the genetic mechanism for how acute myeloid leukemia cells with a specific DNA mutation stay as undifferentiated cells.
Fred Hutchinson Cancer Research Center will host one of hundreds of summits held around the country on June 29 in conjunction with the Vice President Joe Biden's Cancer Moonshot Summit in Washington, DC. The goal of the Cancer Moonshot...Show More Summary
Brittany Woods nervously bites her fingernails as she tries to get a hold of someone at The Don & Sybil Harrington Cancer Center to reschedule her chemotherapy treatment.
A phase 1 clinical trial testing a novel combination therapy developed by scientists at VCU Massey Cancer Center slowed the growth of cancer in the majority of trial participants, which were patients with advanced solid tumors. Approximately...Show More Summary
A phase 1 clinical trial testing a novel combination therapy developed by scientists at VCU Massey Cancer Center slowed the growth of cancer in the majority of trial participants, which were patients with advanced solid tumors.
Today, The Abramson Cancer Center at the University of Pennsylvania, The Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and The TischShow More Summary
The University of Texas MD Anderson Cancer Center will join institutions across the country in the inaugural national Cancer Moonshot Summit, convened at the request of Vice President Joe Biden, on June 29.
TAMPA, Fla. (June 20, 2016) - Tumors are composed of many subpopulations of cells. A general consensus among scientists is that these subpopulations are due to random mutations. However, Moffitt Cancer Center researchers found that these assumptions may be incorrect. Show More Summary
Moffitt Cancer Center researchers found that these assumptions may be incorrect. In a new article published in the journal Cancer Research, they report that certain subpopulations can be predicted and do not develop randomly as previously thought.
New research by scientists at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas MD Anderson Cancer Center sheds light on the link between obesity and cancer.
Andrew L. Kung, MD, PhD, has been named the new Chairman of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center (MSK). An accomplished physician, researcher, leader, and mentor, Dr. Kung most recently served as the...Show More Summary
Researchers from Harvard say that 40 percent of cancer cases and about half of all cancer deaths are caused by poor lifestyle habits. According to the Centers for Disease Control and Prevention, cancer is a leading cause of death in the US–a very close 2nd to heart disease, in fact. A recent study published in the Journal of the American […]
In summer 2011, University of Colorado Cancer Center investigators Joaquín Espinosa, PhD, and Matthew Galbraith, PhD, taught a summer symposium on gene expression at Cold Spring Harbor Laboratory in Long Island, New York. As part of the three-week course, one of their students, Joel Perrez-Perri from Dr. Show More Summary
The role of TIP60 (alongside previously known CDK8) in allowing human colorectal cancer cells to survive at the oxygen-poor centers of tumors is now better understood, thanks to new research.
University of Colorado Cancer Center study in Cell Reports shows role of TIP60 in allowing human colorectal cancer cells to survive at the oxygen-poor centers of tumors.
New research from The University of New Mexico Comprehensive Cancer Center sheds light on how the cells of one type of cancer cheat death. In a paper published in Oncotarget, Alexandre Chigaev, PhD, and his team describe the apoptosis-evading process that leukemia cells use. The team also discovered that some approved drugs can fight this process
Gary H. Lyman, MD, MPH, an internationally recognized oncologist and health economist at Fred Hutchinson Cancer Research Center and a member of a committee of the National Academies of Sciences, Engineering, and Medicine (NASEM), is available to discuss biomarker tests for molecularly targeted therapies. Show More Summary
Researchers at Columbia University's Mailman School of Public Health and Columbia University Medical Center, and NewYork-Presbyterian, found that patients who did not adhere to their medication schedule for chronic conditions, such as...Show More Summary
The University of New Mexico Health Sciences Center has joined a national network of scientists on the leading edge of drug discovery and development in the fight against cancer, centered at the Frederick National Laboratory for Cancer Research.